Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan
Clinical trial NCT02975440 · COMPLETED
Trial details
- NCT number
- NCT02975440
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-10
- Primary completion
- 2017-01-27
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.